Effect of preeclampsia on placental function: Influence of sexual dimorphism, microRNA's and mitochondria

Advances in Experimental Medicine and Biology

Volumn 814, Issue , 2014, Pages 133-146

  Myatt, Leslie ^a   Muralimanoharan, Sribalasubashini ^a   Maloyan, Alina ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Fetus; Inflammation; Mitochondria; Obesity; Oxidative stress; Placenta; Preeclampsia; Pregnancy; Sexual dimorphism

Indexed keywords

GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 210; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN;

APOPTOSIS; ARTICLE; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOWN REGULATION; FETUS OUTCOME; GENE EXPRESSION REGULATION; GLUT 1 GENE; HIF 1ALPHA GENE; HUMAN; INFLAMMATION; MITOCHONDRIAL GENE; MITOCHONDRION; MOLECULAR INTERACTION; OXIDATIVE STRESS; PLACENTA DISORDER; PLACENTA FUNCTION; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; SEX DIFFERENCE; UPREGULATION; VEGF GENE; FEMALE; GENETICS; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; PLACENTA; PREGNANCY; SEXUAL DEVELOPMENT;

FEMALE; HUMANS; MALE; MICRORNAS; MITOCHONDRIA; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; SEX CHARACTERISTICS;

EID: 84921669318     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-1-4939-1031-1_12     Document Type: Article

References (110)

1. Vitoratos N, Vrachnis N, Iavazzo C, Kyrgiou M. Preeclampsia: molecular mechanisms, predisposition, and treatment. J Pregnancy. 2012;2012:145487.
2. Hogberg U. The World Health Report 2005: " make every mother and child count"-including Africans. Scand J Public Health. 2005;33:409-11.
3. Myatt L,Miodovnik M. Prediction of preeclampsia Semin Perinatol. 1999 23,45-57.
4. Redman CW, Sargent IL. Preeclampsia and the systemic inflammatory response. Semin Nephrol. 2004;24:565-70.
5. Staff AC, Benton SJ, von Dadelszen P, Roberts JM, Taylor RN, Powers RW, et al. Redefining preeclampsia using placenta-derived biomarkers. Hypertension. 2013;61:932-42.
6. Myatt L. Role of placenta in preeclampsia. Endocrine. 2002;19:103-11.
7. Rampersad R, Nelson DM. Trophoblast biology, responses to hypoxia and placental dysfunction in preeclampsia. Front Biosci. 2007;12:2447-56.
8. Fugelseth D, Ramstad HB, Kvehaugen AS, Nestaas E, Stoylen A, Staff AC. Myocardial function in offspring 5-8 years after pregnancy complicated by preeclampsia. Early Hum Dev. 2011;87:531-5.
9. Jayet PY, Rimoldi SF, Stuber T, Salmon CS, Hutter D, Rexhaj E, et al. Pulmonary and systemic vascular dysfunction in young offspring of mothers with preeclampsia. Circulation. 2010;122:488-94.
10. Lazdam M, de la Horra A, Diesch J, Kenworthy Y, Davis E, Lewandowski AJ, et al. Unique blood pressure characteristics in mother and offspring after early onset preec lampsia. Hypertension. 2012;60:1338-45.
11. Clifton VL. Review: sex and the human placenta: mediating differential strategies of fetal growth and survival. Placenta. 2010;31(Suppl):S33-9.
12. Eriksson JG, Kajantie E, Osmond C, Thornburg K, Barker DJ. Boys live dangerously in the womb. Am J Hum Biol. 2010;22:330-5.
13. Vatten LJ, Skjaerven R. Offspring sex and pregnancy outcome by length of gestation. Early Hum Dev. 2004;76:47-54.
14. Makhseed M, Musini VM, Ahmed MA. Association of fetal gender with pregnancy-induced hypertension and pre-eclampsia. Int J Gynaecol Obstet. 1998;63:55-6.
15. Challis J, Newnham J, Petraglia F, Yeganegi M, Bocking A. Fetal sex and preterm birth. Placenta. 2013;34:95-9.
16. Murphy VE, Gibson PG, Giles WB, Zakar T, Smith R, Bisits AM, et al. Maternal asthma is associated with reduced female fetal growth. Am J Respir Crit Care Med. 2003;168:1317-23.
17. Murphy VE, Gibson P, Talbot PI, Clifton VL. Severe asthma exacerbations during pregnancy. Obstet Gynecol. 2005;106:1046-54.
18. Stark MJ, Dierkx L, Clifton VL, Wright IMR. Alterations in the maternal peripheral microvascular response i n pregnancies complicated by preeclampsia and the impact of fetal sex. J Soc Gynecol Investig. 2006;13:573-8.
19. Stark MJ, Clifton VL, Wright IMR. Sex-specific differences in peripheral microvascular blood flow in preterm infants. Pediatr Res. 2008;63:415-9.
20. Stark MJ, Wright IM, Clifton VL. Sex-specific alterations in placental 11beta-hydroxysteroid dehydrogenase 2 activity and early pos tnatal clinical course following antenatal betamethasone. Am J Physiol Regul Integr Comp Physiol. 2009;297:R510-4.
21. Wu G, Imhoff-Kunsch B, Girard AW. Biological mechanisms for nutritional regulation of maternal health and fetal development. Paediatr Perinat Epidemiol. 2012;26 Suppl 1:4-26.
22. Myatt L. Placental adaptive responses and fetal programming. J Physiol. 2006;572:25-30.
23. Sood R, Zehnder JL, Druzin ML, Brown PO. Gene expression patterns in human placenta. Proc Natl Acad Sci U S A. 2006;103:5478-83.
24. Osei-Kumah A,Smith R,Jurisica I,Caniggia I,Clifton VL. Sex-specific differences in placental global gene expression in pregnancies complicated by asthma Placenta. 2011 32,570-8.
25. Scott NM, Hodyl NA, Murphy VE, Osei-Kumah A, Wyper H, Hodgson DM, et al. Placental cytokine expression covaries with maternal asthma severity and fetal sex. J Immunol. 2009;182:1411-20.
26. Prescott SL, Clifton V. Asthma and pregnancy: emerging evidence of epigenetic interactions in utero. Curr Opin Allergy Clin Immunol. 2009;9:417-26.
27. Clifton VL. Sexually dimorphic effects of maternal asthma during pregnancy on placental glucocorticoid metabolism and fetal growth. Cell Tissue Res. 2005;322:63-71.
28. Mao J, Zhang X , Sieli PT, Falduto MT, Torres KE, Rosenfeld CS. Contrasting effects of different maternal diets on sexually dimorphic gene expression in the murine placenta. Proc Natl Acad Sci U S A. 2010;107:5557-62.
29. Yeganegi M, Leung CG, Martins A, Kim SO, Reid G, Challis JR, et al. Lactobacillus rhamnosus GR-1 stimulates colony-stimulating factor 3 (granulocyte) (CSF3) output in placental trophoblast cells in a fetal sex-dependent manner. Biol Reprod. 2011;84:18-25.
30. Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol. 2008;8:737-44.
31. Steier JA, Ulstein M, Myking OL. Human chorionic gonadotropin and testosterone in normal and preeclamptic pregnancies in relation to fetal sex. Obstet Gynecol. 2002;100:552-6.
32. Laivuori H, Kaaja R, Rutanen EM, Viinikka L, Ylikorkala O. Evidence of high circulating testosterone in women with prior preeclampsia. J Clin Endocrinol Metab. 1998;83:344-7.
33. Acromite MT, Mantzoros CS, Leach RE, Hurwitz J, Dorey LG. Androgens in preeclampsia. Am J Obstet Gynecol. 1999;180:60-3.
34. Salamalekis E, Bakas P, Vitoratos N, Eleptheriadis M, Creatsas G. Androgen levels in the third trimester of pregnancy in patients with preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2006;126:16-9.
35. Sathishkumar K, Balakrishnan M, Chinnathambi V, Chauhan M, H ankins GD, Yallampalli C. Fetal sexrelated dysregulation in testosterone production and their receptor expression in the human placenta with preeclampsia. J Perinatol. 2012;32:328-35.
36. Diaz L, No yola-Martinez N, Barrera D, Hernandez G, Avila E, Halhali A, et al. Calcitriol inhibits TNFalpha-induced inflammatory cytokines in human trophoblasts. J Reprod Immunol. 2009;81:17-24.
37. Jiang B, Kamat A, Mendelson CR. Hypoxia prevents induction of aromatase expression in human trophoblast cells in culture: potential inhibitory role of the hypoxia-inducible transcription factor Mash-2 (mammalian achaete-scute homologous pro tein-2). Mol Endocrinol. 2000;14:1661-73.
38. Christensen A, Froyshov D, Fylling P. Hormone and enzyme assays in pregnancy. IV. The human chorionic somatomammotrophin, placental cystineaminopeptidase, progesterone and the urinary oestrogens in pregnancies complicated with essential hypertension, mild or severe pre-eclampsia. Acta Endocrinol (Copenh). 1974;77:344-55.
39. Muralimanoharan S, Maloyan A, Myatt L. Evidence of sexual dimorphism in the placental function with severe preeclampsia. Placenta. 2013;34:1183-9.
40. Myatt L, Eis AL, Brockman DE, Kossenjans W, Greer IA, Lyall F. Dif ferential localization of superoxide dismutase isoforms in placental villous tissue of normotensive, pre-eclamptic, and intrauterine growth-restricted pregnancies. J Histochem Cytochem. 1997;45:1433-8.
41. Muralimanoharan S, Maloyan A, Mele J, Guo C, Myatt LG, Myatt L. MIR-210 modulates mitochondrial respiration in placenta with preeclampsia. Placenta. 2012;33:816-23.
42. Adelman DM, Gertsenstein M, Nagy A, Simon MC, Maltepe E. Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses. Genes Dev. 2000;14:3191-203.
43. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ. Regulation of human placental development by oxygen tension. Science. 1997;277:1669-72.
44. Caniggia I, Winter JL. Adriana and Luisa Castellucci Award lecture 2001. Hypoxia inducible factor-1: oxygen regulation of trophoblast differentiation in normal and pre-eclamptic pregnancies-A review. Placenta. 2002;23:S47-57.
45. Rajakumar A, Conrad KP. Expression, ontogeny, and regulation of hypoxia-inducible transcription factors in the human placenta. Biol Reprod. 2000;63:559-69.
46. Nevo O, Soleymanlou N, Wu Y, Xu J, Kingdom J, Many A, et al. Increas ed expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am J Physiol Regul Integr Comp Physiol. 2006;291:R1085-93.
47. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359:843-5.
48. Rajakumar A, Brandon HM, Daftary A, Ness R, Conrad KP. Eviden ce for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae. Placenta. 2004;25:763-9.
49. Rolfo A, Many A, Racano A, Tal R, Tagliaferro A, Ietta F, et al. Abnormalities in oxygen sensing define early and late onset preeclampsia as distinct pathologies. PLoS One. 2010;5:e13288.
50. Patel J, Landers K, Mortimer RH, Richard K. Regulation of hypoxia inducible factors (HIF) in hypoxia and normoxia during placental development. Placenta. 2010;31:951-7.
51. DiFederico E, Genbacev O, Fisher SJ. Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol. 1999;155:293-301.
52. Allaire AD, Ballenger KA, Wells SR, McMahon MJ, Lessey BA. Placental apoptosis in preeclampsia. Obstet Gynecol. 2000;96:271-6.
53. Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T. Increased apoptosis in the syncytiotrophoblast in human te rm placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol. 2002;186:158-66.
54. Kilani RT, Mackova M, Davidge ST, Guilbert LJ. Effect of oxygen levels in villous trophoblast apoptosis. Placenta. 2003;24:826-34.
55. Levy R, Smith SD, Chandler K, Sadovsky Y, Nelson DM. Apoptosis in human cultured trophoblasts is enhanced by hypoxia and dim inished by epidermal growth factor. Am J Physiol Cell Physiol. 2000;278:C982-8.
56. Taylor CT, Cummins EP. The role of NF-kappaB in hypoxia-induced gene expression. Ann N Y Acad Sci. 2009;1177:178-84.
57. Gorlach A, Bonello S. The cross-talk between NF-kappaB and HIF-1: further evidence for a significant liaison. Biochem J. 2008;412:e17-9.
58. Carbia-Nagashima A, Gerez J, Perez-Castro C, Paez-Pereda M, Silberstein S, Stalla GK, et al. RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia. Cell. 2007;131:309-23.
59. Roebuck KA. Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB (review). Int J Mol Med. 1999;4:223-30.
60. Matsushita H, Morishita R, Nata T, Aoki M, Nakagami H, Taniyama Y, et al. Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation. Circ Res. 2000;86:974-81.
61. Vaughan JE, Walsh SW. Activation of NF-kappaB in placentas of women with preeclampsia. Hypertens Pregnancy. 2012;31:243-51.
62. Myatt L. Review: reactive oxygen and nitrogen species and functional adaptation of the placenta. Placenta. 2010;31(Suppl):S66-9.
63. Wang Y, Walsh SW. Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression i n placental trophoblast cells in pre-eclampsia. Placenta. 2001;22:206-12.
64. Van Houten B, Woshner V, Santos JH. Role of mitochondrial DNA in toxic responses to oxidative stress. DNA Repair (Amst). 2006;5:145-52.
65. Lee H-C, Wei Y-H. Oxidative stress, mitochondrial DNA mutation, and apoptosis in aging. Exp Biol Med (Maywood). 2007;232:592-606.
66. Myatt L, Cui X. Oxidative stress in the placenta. Histochem Cell Biol. 2004;122:369-82.
67. Torbergsen T,Oian P,Mathiesen E,Borud O Preeclampsia-A mitochondrial disease? Acta Obstet Gynecol Scand. 1989 68, 145-8.
68. Yogev Y, Visser GH. Obesity, gestational diabetes and pregnancy outcome. Semin Fetal Neonatal Med. 2009;14:77-84.
69. Rogers LK, Velten M. Maternal inflammation, growth retardation, and preterm birth: insights into adult cardiovascular disease. Life Sci. 2011;89:417-21.
70. Zhu MJ, Du M, Na thanielsz PW, Ford SP. Maternal obesity up-regulates inflammatory signaling pathways and enhances cytokine expression in the midgestation sheep placenta. Placenta. 2010;31:387-91.
71. Feldmann HM, Golozoubova V, Cannon B, Nedergaard J. UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality. Cell Metab. 2009;9:203-9.
72. Wilson-Fritch L, Nicoloro S, Chouinard M, Lazar MA, Chui PC, Leszyk J, et al. Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J Clin Invest. 2004;114:1281-9.
73. Boudina S, Sena S, O'Neill BT, Tathireddy P, Young ME, Abel ED. Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation. 2005;112: 2686-95.
74. Bax BE, Bloxam DL. Energy metabolism and glycolysis in human placental trophoblast cells during differentiation. Biochim Biophys Acta. 1997;1319:283-92.
75. Llu rba E, Gratacós E, Martín-Gallá n P, Cabero L, Dominguez C. A comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy. Free Radic Biol Med. 2004;37:557-70.
76. Watson AL, Skepper JN, Jauniaux E, Burton GJ. Susceptibility of human placental syncytiotrophoblastic mitochondria to oxygen-mediated damage in relation to gestational age. J Clin Endocrinol Metab. 1998;83: 1697-705.
77. Wang Y, Walsh SW. Placental mitochondria as a source of oxidative stress in pre-eclampsia. Placenta. 1998;19:581-6.
78. Lattuada D, Colleoni F, Martinelli A, Garretto A, Magni R, Radaelli T, et al. Higher mitochondrial DNA content in human IUGR placenta. Placenta. 2008;29:1029-33.
79. Valsamakis G, Kanaka-Gantenbein C, Malamitsi-Puchner A, Mastorakos G. Causes of intrauterine growth restriction and the postnatal development of the metabolic syndrome. Ann N Y Acad Sci. 2006;1092:138-47.
80. Poston L, Igosheva N, Mistry HD, Seed PT, Shennan AH, Rana S, et al. Role of oxidative stress and anti-oxidant supplementation in pregnancy disorders. Am J Clin Nutr. 2011;94(6 Suppl):1980S-5S.
81. Yan L, Ge H, Li H, Lieber SC, Natividad F, Resuello RRG, et al. Gender-specific proteomic alterations in glycolytic and mitochondrial pathways in aging monkey hearts. J Mol Cell Cardiol. 2004;37:921-9.
82. Justo R, B oada J, Frontera M, Oliver J, Bermú dez J, Gianotti M. Gender dimorphism in rat liver mitochondrial oxidative metabolism and biogenesis. Am J Physiol Cell Physiol. 2005;289:C372-8.
83. A rnold S, de Araú jo GW, Beyer C. Gender-specific regulation of mitochondrial fusion and fission gene transcription and viability of cortical astrocytes by steroid hormones. J Mol Endocrinol. 2008;41:289-300.
84. Sanz A, Hiona A, Kujoth GC, Seo AY, Hofer T, Kouwenhoven E, et al. Evaluation of sex differences on mitochondrial bioenergetics and apoptosis in mice. Exp Gerontol. 2007;42:173-82.
85. Lagranha CJ, Deschamps A, Aponte A, Steenbergen C, Murphy E. Sex differences in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in females. Circ Res. 2010;106:1681-91.
86. Widschwendter M, Schrocksnadel H, Mortl MG. Pre-eclampsia: a disorder of placental mitochondria? Mol Med Today. 1998;4:286-91.
87. Bereiter-Hahn J, Voth M. Dynamics of mitochondria in living cells: shape changes, dislocations, fusion, and fission of mitochondria. Microsc Res Tech. 1994;27:198-219.
88. Karbowski M,Youle RJ. Dynamics of mitochondrial morphology in healthy cells and during apoptosis Cell Death Differ. 2003 10,870-80.
89. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215-33.
90. Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol. 2010;11:252-63.
91. Enquobahrie DA, Abetew DF, Sorensen TK, Willoughby D, Chidambaram K, Williams MA. Placental microRNA expression in pregnancies complicated by preeclampsia. Am J Obstet Gynecol. 2011;204:178. e12-21.
92. Ishibashi O, Ohkuch i A, Ali MM, Kurashina R, Luo SS, Ishikawa T, et al. Hydroxysteroid (17-beta) dehydrogenase 1 is dysregulated by mir-210 and mir-518c that are aberrantly expressed in preeclamptic placentas: a novel marker for predicting preeclamp sia. Hypertension. 2012;59:265-73.
93. Lee DC, Romero R, Kim JS, Tarca AL, Montenegro D, Pineles BL, et al. miR-210 targets iron-sulfur cluster scaffold homologue in human trophoblast cell lines: siderosis of interstitial trophoblasts as a novel pathology of preterm preeclampsia and smallfor-gestational-Age pregnancies. Am J Pathol. 2011;179:590-602.
94. Liu C, Zhou Y, Zhang Z. MiR-210: an important player in the pathogenesis of preeclampsia? J Cell Mol Med. 2012;16:943-4.
95. Pineles BL, Romero R, Montenegro D, Tarca AL, Han YM, Kim YM, et al. Distinct sub sets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol. 2007;196:261. e1-6.
96. Zhu XM, Han T, Sargent IL, Yin GW, Yao YQ. Different ial expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies. Am J Obstet Gynecol. 2009;200:661. e1-7.
97. Zhang Y, Fei M, Xue G, Zhou Q, Jia Y, Li L, et al. Elevated levels of hypoxia-inducible microRNA-210 in pre-eclampsia: new insights into molecular mechanisms for the disease. J Cell Mol Med. 2012;16:249-59.
98. Huang X, Ding L, Bennewith KL, Tong RT, Welford SM, Ang KK, et al. Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol Cell. 2 009;35:856-67.
99. Chen Z, Li Y, Zhang H, Huang P, Luthra R. Hypoxiaregulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression. Oncogene. 2010;29:4362-8.
100. Favaro E, Ramachandran A, McCormick R, Gee H, Blancher C, Crosby M, et al. MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by target ing iron sulfur cluster protein ISCU. PLoS One. 2010;5:e10345.
101. Ivan M, Harris AL, Martelli F, Kulshreshtha R. Hypoxia response and microRNAs: no longer two separate worlds. J Cell Mol Med. 2008;12:1426-31.
102. Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ, et al. A microRNA signature of hypoxia. Mol Cell Biol. 2007;27:1859-67.
103. Nakada C, Tsukamoto Y, Matsuura K, Nguyen TL, Hijiya N, Uchida T, et al. Overexpression of miR-210, a downstream target of HIF1alpha, causes centrosome amplification in renal carcinoma cells. J Pathol. 2011;224:280-8.
104. Chan YC, Banerjee J, Choi SY, Sen CK. miR-210: the master hypoxamir. Microcirculation. 2012;19:215-23.
105. Devlin C, Greco S, Martelli F, Ivan M. miR-210: more than a silent player in hypoxia. IUBMB Life. 2011;63:94-100.
106. Chan SY, Zhang YY, Hemann C, Mahoney CE, Zweier JL, Loscalzo J. MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab. 2009;10:273-84.
107. Puissegur MP, Mazure NM, Bertero T, Pradelli L, Grosso S, Robbe-Sermesant K, et al. miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterat ions associated with modulation of HIF-1 activity. Cell Death Differ. 2011;18:465-78.
108. Harner M, Korner C, Walther D, Mokranjac D, Kaesmacher J, Welsch U, et al. The mitochondria l contact site complex, a determinant of mitochondrial architecture. EMBO J. 2011;30:4356-70.
109. Moran M, Rivera H, Sanchez-Arago M, Blazquez A, Merinero B, Ugalde C, et al. Mitoch ondrial bioenergetics and dynamics interplay in complex I-deficient fibroblasts. Biochim Biophys Acta. 1802;2010:443-53.
110. Dranka BP, Hill BG, Darley-Usmar VM. Mitochondrial reserve capacity in endothelial cells: the impact of nitric oxide and reactive oxygen species. Free Radic Biol Med. 2010;48:905-14.